ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,901 | 52.961 | 1 | male | 1 | 7 | 7 | Lung Cancer | Cancer | 1 | null | null | 41 | 8,388 | 5,345.3594 | null | 12 | black | 29.699219 | 15 | 0.212982 | 0.021999 | 1 | 0 | 0 | metastatic | 0.05 | 0.000125 | dnr before sadm | -1 | 83 | 32.195313 | 112 | 16 | 37.39844 | null | 2.799805 | 1.099854 | 0.699951 | 142 | null | null | null | null | null | 1 | <2 mo. follow-up | 1 |
1,902 | 62.25098 | 0 | female | 0 | 5 | 1,779 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 5,801 | 3,634.0312 | null | 7 | white | 18.296875 | 17 | 0.891968 | 0.81897 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 110 | 17.296875 | 100 | 20 | 36.69531 | 176.65625 | 3.899902 | 0.399963 | 1.199951 | 143 | 7.30957 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
1,903 | 63.54797 | 0 | female | 0 | 18 | 1,778 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 35,637 | 15,254.7578 | null | 20.666656 | white | 20.699219 | 34 | 0.863892 | 0.773926 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 18 | 147 | 8.199219 | 115 | 6 | 37.79688 | 140 | 4.199219 | 1.5 | 1.399902 | 148 | 7.299805 | null | null | null | null | 1 | null | 1 |
1,904 | 71.30695 | 0 | female | 0 | 19 | 1,777 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 35,785 | 29,547.8125 | null | 27 | white | 30.699219 | 49 | 0.600952 | 0.493958 | 5 | 1 | 0 | no | 0.75 | 0.7 | dnr after sadm | 4 | 68 | 10.199219 | 103 | 32 | 38.39844 | 61 | null | null | 1.599854 | 134 | 7.489258 | null | null | null | null | 5 | SIP>=30 | 5 |
1,905 | 70.15497 | 1 | male | 0 | 4 | 51 | Lung Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 4,469 | 2,853.1348 | null | 9 | white | 18.597656 | 10 | 0.661987 | 0.360962 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 4 | 80 | 20.296875 | 90 | 20 | 37.79688 | null | 3.299805 | 0.5 | 0.699951 | 137 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
1,906 | 61.98798 | 1 | male | 0 | 7 | 225 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $11-$25k | 0 | 20,414 | 7,250.3516 | null | 30 | white | 34.898438 | 56 | 0.422974 | 0.303955 | 1 | 0 | 0 | yes | 0.75 | 0.5 | no dnr | 7 | 52 | 5.5 | 110 | 12 | 38.89844 | 145 | 1.699951 | 1.699951 | 1.899902 | 131 | 7.30957 | null | null | null | null | 0 | SIP>=30 | 0 |
1,907 | 75.737 | 1 | female | 0 | 7 | 1,215 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 11,378 | 6,638.8867 | null | 16 | white | 17.199219 | 18 | 0.860962 | 0.769897 | 1 | 0 | 0 | no | 0.99 | 0.97 | no dnr | 7 | 77 | 13.099609 | 100 | 20 | 37.19531 | 295.1875 | null | null | 0.899902 | 139 | 7.439453 | null | null | null | 1 | 2 | no(M2 and SIP pres) | 2 |
1,908 | 57.09198 | 0 | male | 0 | 15 | 1,775 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 7 | null | 0 | 40,735 | 20,608.4844 | null | 26.666656 | white | 18.898438 | 28 | 0.885986 | 0.845947 | 1 | 1 | 0 | no | 0.9 | 0.95 | no dnr | 15 | 58 | 6.699219 | 110 | 24 | 38.59375 | 280 | null | null | 0.899902 | 136 | 7.489258 | null | null | null | 5 | 0 | no(M2 and SIP pres) | 0 |
1,909 | 83.55896 | 1 | male | 0 | 7 | 928 | COPD | COPD/CHF/Cirrhosis | 1 | null | under $11k | 0 | 9,225 | 6,452.3867 | null | 11 | white | 26.898438 | 46 | 0.615967 | 0.429993 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 7 | 107 | 16.796875 | 60 | 25 | 36.69531 | 117.5 | null | null | 1.5 | 144 | 7.279297 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
1,910 | 53.54999 | 1 | male | 0 | 22 | 904 | CHF | COPD/CHF/Cirrhosis | 3 | 16 | >$50k | 0 | 47,802 | 29,025.8438 | null | 19.666656 | white | 21.796875 | 29 | 0.875 | 0.792969 | 1 | 1 | 0 | no | 0.99 | 0.99 | no dnr | 22 | 77 | 7.5 | 63 | 24 | 36.69531 | 170 | null | null | 1.899902 | 144 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,911 | 66.58698 | 1 | male | 0 | 6 | 359 | Lung Cancer | Cancer | 1 | 13 | >$50k | 0 | 7,248 | 4,762.5352 | null | 12 | white | 22.296875 | 18 | 0.584961 | 0.264954 | 1 | 0 | 0 | metastatic | 0.9 | 0.65 | no dnr | 6 | 100 | 3 | 100 | 20 | 35.59375 | null | 3.099609 | 0.199982 | 1.099854 | 137 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,912 | 89.16095 | 1 | male | 1 | 62 | 62 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | under $11k | 9 | 74,657 | 46,843.25 | null | 14.75 | white | 28.5 | 55 | 0.571899 | 0.461975 | 1 | 0 | 0 | no | 0.85 | 0.75 | dnr after sadm | 57 | 47 | 9.099609 | 72 | 26 | 38.39844 | 203.3125 | null | null | 2.5 | 138 | 7.269531 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
1,913 | 85.45697 | 1 | male | 0 | 11 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 0 | 31,884 | 20,765.8125 | null | 32.5 | white | 30.796875 | 50 | 0.40094 | 0.280945 | 8 | 0 | 1 | yes | 0.8 | 0.65 | dnr after sadm | 10 | 46 | 10.199219 | 105 | 28 | 36.29688 | 346.625 | 2.299805 | 1.299805 | 1.5 | 138 | 7.269531 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
1,914 | 66.53296 | 0 | male | 0 | 9 | 1,771 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $11-$25k | 0 | 14,115 | 6,797.5898 | null | 18 | white | 17.296875 | 33 | 0.879883 | 0.836914 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 9 | 55 | 7 | 68 | 24 | 38.79688 | 252.5 | 2.899902 | 0.299988 | 1.5 | 141 | 7.389648 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,915 | 64.34998 | 1 | female | 1 | 6 | 6 | Colon Cancer | Cancer | 1 | null | null | 0 | 4,814 | 3,547.2793 | null | 12 | white | 40.796875 | 25 | 0.25 | 0.031998 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 1 | 93 | 11.798828 | 100 | 20 | 36.09375 | null | 1.899902 | 4.399414 | 0.899902 | 146 | null | null | null | null | null | null | <2 mo. follow-up | 2.105469 |
1,916 | 91.23895 | 1 | female | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | null | 0 | 49,254 | 17,402.25 | null | 38.333313 | white | 25.199219 | 41 | 0.606934 | 0.500977 | 1 | 0 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 16 | 47 | 8.798828 | 47 | 8 | 36.89844 | 230 | null | 0.5 | 1.299805 | 137 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 3.51416 |
1,917 | 52.43799 | 1 | male | 0 | 4 | 63 | Lung Cancer | Cancer | 3 | null | null | 0 | 3,754 | 2,510.0801 | null | 7 | white | 9.5 | 15 | 0.846924 | 0.662964 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 4 | 90 | 10.5 | 90 | 20 | 37.79688 | 342.8125 | 4.099609 | 2.099609 | 1.299805 | 136 | 7.489258 | null | null | null | null | null | null | 2.921875 |
1,918 | 69.68695 | 0 | female | 0 | 6 | 1,768 | Lung Cancer | Cancer | 2 | 16 | >$50k | 0 | 7,594 | 4,807.0508 | null | 13 | white | 14.798828 | 15 | 0.73999 | 0.473999 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 97 | 4.099609 | 100 | 20 | 38.19531 | 280.9375 | null | null | 1 | 144 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,919 | 68.01099 | 1 | female | 0 | 40 | 1,608 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 13 | $25-$50k | 0 | 65,515 | 35,741.6875 | null | 21.25 | white | 24.796875 | 30 | 0.750977 | 0.671997 | 4 | 0 | 1 | no | 0.5 | 0.5 | no dnr | 40 | 53 | 11.199219 | 70 | 8 | 38.59375 | 182 | null | null | 1.099854 | 157 | 7.429688 | null | null | null | null | 0 | null | 0 |
1,920 | 78.00995 | 1 | male | 1 | 26 | 26 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 9 | 55,591 | 25,233.4688 | null | 15.5 | white | 23.597656 | 40 | 0.705933 | 0.544922 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 20 | 117 | 16.898438 | 70 | 20 | 35.59375 | 169.5625 | 3.599609 | 0.399963 | 1.699951 | 146 | 7.319336 | null | null | null | null | null | <2 mo. follow-up | 2.724609 |
1,921 | 66.57599 | 1 | male | 0 | 32 | 58 | Lung Cancer | Cancer | 1 | 10 | $11-$25k | 0 | 28,609 | 21,191.9844 | null | 9.75 | hispanic | 16.398438 | 11 | 0.715942 | 0.435974 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 87 | 13.398438 | 60 | 20 | 37 | null | 3.599609 | 0.599976 | 0.899902 | 133 | null | null | null | null | null | null | <2 mo. follow-up | 2.816406 |
1,922 | 71.55096 | 1 | male | 0 | 4 | 42 | Lung Cancer | Cancer | 1 | 13 | null | 0 | 4,155 | 2,700.1113 | null | 6 | white | 24.398438 | 33 | 0.511963 | 0.189972 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 1 | 60 | 12.599609 | 110 | 25 | 36.79688 | 323.75 | 3.099609 | 0.399963 | 1 | 143 | 7.419922 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
1,923 | 93.63196 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 20,328 | 6,779.9258 | null | 34 | white | 29.097656 | 51 | 0.487 | 0.368958 | 1 | 0 | 1 | yes | 0.5 | 0.1 | dnr after sadm | 6 | 55 | 12.099609 | 62 | 36 | 36.79688 | 177.5 | null | 0.799927 | 2.199707 | 139 | 7.379883 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
1,924 | 55.51498 | 1 | male | 0 | 3 | 410 | Lung Cancer | Cancer | 3 | 8 | $11-$25k | 0 | 4,136 | 2,525.0195 | null | 6 | white | 16.898438 | 9 | 0.731934 | 0.461975 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 3 | 100 | 11.699219 | 92 | 20 | 36.69531 | null | null | null | 0.799927 | 137 | null | null | null | null | 0 | 1 | SIP>=30 | 1 |
1,925 | 84.80499 | 1 | female | 0 | 13 | 35 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 9 | 13,374 | 9,147.9844 | null | 10 | white | 23.699219 | 40 | 0.700928 | 0.537964 | 1 | 1 | 1 | no | 0.9 | 0.5 | dnr after sadm | 10 | 107 | 6 | 80 | 20 | 35.59375 | 276 | 3 | 0.5 | 2.399902 | 136 | 7.5 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
1,926 | 46.08398 | 0 | female | 0 | 10 | 1,761 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 9,901 | 7,630.4258 | null | 3 | black | 13.798828 | 6 | 0.800903 | 0.575928 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 1 | 93 | 12.699219 | 76 | 16 | 36.69531 | null | 3.599609 | 0.399963 | 1 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,927 | 53.99597 | 0 | male | 0 | 11 | 1,759 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | under $11k | 0 | 14,066 | 7,690.0742 | null | 19 | black | 23.5 | 21 | 0.846924 | 0.794922 | 1 | 0 | 0 | no | 1 | 0.95 | no dnr | 11 | 64 | 11.699219 | 110 | 25 | 38.09375 | 179.5625 | null | null | 0.799927 | 136 | 7.449219 | null | null | null | null | null | null | 2.565918 |
1,928 | 44.89499 | 0 | female | 0 | 63 | 1,757 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | $25-$50k | 0 | 176,328 | 64,412.5625 | null | 50.75 | white | 42.398438 | 70 | 0.522949 | 0.407959 | 1 | 0 | 0 | no | 0.15 | 0.00337 | no dnr | 63 | 53 | 41.195313 | 130 | 22 | 36.39844 | 50 | 1.899902 | 1.199951 | 1.5 | 129 | 7.279297 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,929 | 67.75098 | 1 | male | 1 | 10 | 10 | MOSF w/Malig | ARF/MOSF | 1 | 8 | under $11k | 0 | 46,516 | 22,635.3438 | null | 43 | white | 25.898438 | 63 | 0.566895 | 0.454956 | 10 | 0 | 0 | yes | 0.75 | 0.5 | dnr after sadm | 8 | 57 | 12.199219 | 145 | 14 | 36.89844 | 211.65625 | null | 0.5 | 11.798828 | 138 | 7.319336 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
1,930 | 75.159 | 1 | female | 1 | 6 | 6 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 24,431 | 10,405.8281 | null | 39 | white | 45.695313 | 58 | 0.138977 | 0.031998 | 4 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 6 | 43 | 29.398438 | 127 | 24 | 34.59375 | 195 | 2.799805 | null | 1.199951 | 132 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,931 | 69.59094 | 1 | male | 0 | 6 | 816 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 5,894 | 3,981.5547 | null | 15 | white | 24.199219 | 48 | 0.792969 | 0.666992 | 1 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 6 | 63 | 11 | 80 | 25 | 35.59375 | 224 | null | 1.599854 | 2.199707 | 135 | 7.489258 | null | null | null | 0 | 0 | SIP>=30 | 0 |
1,932 | 31.76999 | 1 | male | 0 | 23 | 72 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 33,867 | 22,225.9375 | null | 18.666656 | white | 24 | 20 | 0.642944 | 0.333984 | 1 | 0 | 0 | metastatic | 0.8 | 0.25 | no dnr | 23 | 72 | 16.796875 | 124 | 20 | 39.39844 | null | null | null | 0.599976 | 133 | null | null | null | null | 5 | 2 | adl>=4 (>=5 if sur) | 2 |
1,933 | 74.83398 | 1 | female | 1 | 7 | 7 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 10,763 | 6,619.1445 | null | 15 | white | 26 | 47 | 0.738892 | 0.590942 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 70 | 11.898438 | 100 | 50 | 36.09375 | 263.3125 | 2.199707 | 0.399963 | 0.799927 | 142 | 7.429688 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
1,934 | 74.66699 | 1 | male | 0 | 25 | 1,323 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 46,033 | 19,954.7188 | null | 30 | white | 36.398438 | 67 | 0.492981 | 0.375977 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 25 | 52 | 13 | 113 | 32 | 37.59375 | 120 | 2.099609 | 0.399963 | 2 | 150 | 7.479492 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
1,935 | 69.68097 | 0 | female | 0 | 6 | 1,753 | Lung Cancer | Cancer | 1 | 20 | >$50k | 0 | 6,840 | 4,699.6172 | null | 14 | white | 16.097656 | 17 | 0.714966 | 0.434998 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 6 | 77 | null | 74 | 20 | 36.79688 | null | 3.199707 | 0.299988 | 1 | 139 | null | null | null | null | null | 0 | null | 0 |
1,936 | 75.66895 | 1 | male | 0 | 8 | 64 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 0 | 20,399 | 17,433.4219 | null | 18.5 | white | 21.699219 | 27 | 0.765991 | 0.690918 | 5 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 8 | 108 | 5.599609 | 78 | 24 | 36.59375 | 173.3125 | 2.699707 | null | 1.799805 | 140 | 7.389648 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,937 | 70.09698 | 0 | male | 0 | 4 | 1,750 | COPD | COPD/CHF/Cirrhosis | 1 | 14 | $11-$25k | 0 | 6,388 | 3,125.3809 | null | 9 | white | 17.5 | 16 | 0.86792 | 0.780884 | 1 | 0 | 0 | no | 0.97 | 0.97 | no dnr | 4 | 60 | 10.099609 | 60 | 20 | 36.09375 | 361.875 | null | null | 1.099854 | 144 | 7.319336 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
1,938 | 79.05499 | 1 | female | 0 | 9 | 68 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 9,388 | 6,350.4453 | null | 11 | white | 23.398438 | 43 | 0.603882 | 0.414978 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr before sadm | -1 | 97 | 0.599976 | 76 | 32 | 36.09375 | 190 | 3.099609 | 0.699951 | 0.599976 | 147 | 7.389648 | null | null | null | 5 | 5 | adl>=4 (>=5 if sur) | 5 |
1,939 | 69.06195 | 0 | female | 0 | 9 | 1,749 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 12,943 | 5,987.9141 | null | 12.5 | white | 20 | 33 | 0.845947 | 0.792969 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 9 | 69 | 9.398438 | 72 | 24 | 37.89844 | 348 | 3.099609 | 1.099854 | 4.099609 | 143 | 7.30957 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
1,940 | 83.29596 | 0 | female | 0 | 23 | 1,748 | CHF | COPD/CHF/Cirrhosis | 4 | 13 | null | 0 | 47,413 | 27,751.4062 | null | 16.333328 | white | 24 | 38 | 0.734985 | 0.584961 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 23 | 47 | 5.299805 | 121 | 24 | 37.79688 | null | 3.899902 | 0.299988 | 1.299805 | 146 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,941 | 61.30298 | 0 | male | 0 | 17 | 1,748 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | null | 0 | 37,775 | 27,634.4375 | null | 21.666656 | other | 19.597656 | 26 | 0.869995 | 0.824951 | 1 | 0 | 0 | no | null | null | no dnr | 17 | 68 | 10 | 65 | 32 | 39.09375 | 177.5 | 3.099609 | 0.799927 | 1.299805 | 141 | 7.379883 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,942 | 90.073 | 1 | female | 0 | 8 | 240 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 9,664 | 7,518.3672 | null | 9 | white | 22.199219 | 27 | 0.681885 | 0.588989 | 1 | 0 | 0 | yes | 0.8 | 0.6 | dnr before sadm | -1 | 120 | 4.799805 | 59 | 16 | 36.19531 | 425 | 3.599609 | 0.199982 | 1.5 | 132 | 7.369141 | null | null | null | 4 | 2 | no(M2 and SIP pres) | 2 |
1,943 | 72.59698 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 17 | $11-$25k | 0 | 65,724 | 42,684 | null | 50 | white | 45.09375 | 61 | 0.156982 | 0.076996 | 11 | 0 | 0 | no | 0.4 | 0.2 | no dnr | 3 | 50 | 28.097656 | 120 | 12 | 36.69531 | 100 | 2.599609 | null | 3.5 | 129 | 7.30957 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,944 | 89.28094 | 1 | male | 0 | 11 | 215 | MOSF w/Malig | ARF/MOSF | 4 | 8 | null | 0 | 15,407 | 7,858.9844 | null | 16.5 | white | 37.5 | 68 | 0.292969 | 0.181976 | 1 | 1 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 2 | 50 | 45 | 116 | 28 | 36.09375 | 199.96875 | 3 | null | 5.799805 | 140 | 7.299805 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
1,945 | 78.39795 | 1 | male | 0 | 5 | 1,112 | COPD | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 7,293 | 5,625.7344 | null | 13 | hispanic | 16.898438 | 23 | 0.835938 | 0.731934 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 117 | 8.798828 | 65 | 24 | 37.19531 | 283.3125 | null | null | 1.799805 | 138 | 7.429688 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,946 | 63.44098 | 1 | female | 0 | 7 | 347 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 0 | 13,301 | 7,643.9961 | null | 36 | white | 28.5 | 49 | 0.741943 | 0.660889 | 1 | 1 | 0 | no | 0.75 | 0.5 | no dnr | 7 | 53 | 14.199219 | 100 | 24 | 37.69531 | 355 | 3.599609 | 0.799927 | 4.399414 | 136 | 7.429688 | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
1,947 | 70.90997 | 1 | male | 0 | 7 | 1,069 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 9 | under $11k | 0 | 14,078 | 10,750.4922 | null | 34 | white | 20.796875 | 37 | 0.81897 | 0.757935 | 2 | 1 | 0 | no | null | null | no dnr | 7 | 57 | 9.5 | 112 | 26 | 38.59375 | 224.46875 | null | null | 1 | 136 | 7.519531 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,948 | 48.48499 | 0 | male | 0 | 8 | 1,738 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 0 | 9,580 | 5,006.9414 | null | 14 | white | 29.597656 | 26 | 0.782959 | 0.711914 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 8 | 63 | 6 | 58 | 26 | 35.59375 | 428.5625 | 3 | 3 | 0.5 | 128 | 7.459961 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
1,949 | 75.75897 | 0 | male | 0 | 67 | 1,737 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | $11-$25k | 0 | 101,328 | 73,976.6875 | null | 31.75 | black | 30.398438 | 54 | 0.582886 | 0.472961 | 5 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 67 | 153 | 12.298828 | 130 | 8 | 37.79688 | 145 | null | null | 2.199707 | 134 | 7.40918 | null | null | null | 2 | 0 | SIP>=30 | 0 |
1,950 | 84.57495 | 1 | male | 0 | 15 | 16 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 19,696 | 12,471.5234 | null | 19.666656 | white | 20.5 | 38 | 0.787964 | 0.659912 | 1 | 0 | 0 | no | 0.9 | 0.9 | dnr after sadm | 9 | 107 | 8.199219 | 64 | 32 | 36.09375 | null | 3.799805 | 1.5 | 2.099609 | 145 | null | null | null | null | null | null | <2 mo. follow-up | 3.382324 |
1,951 | 88.50696 | 1 | male | 1 | 10 | 10 | CHF | COPD/CHF/Cirrhosis | 3 | null | under $11k | 9 | 8,194 | 5,980.1562 | null | 8.5 | white | 18 | 31 | 0.784912 | 0.654907 | 1 | 0 | 1 | no | 0.9 | 0.8 | dnr after sadm | 1 | 83 | 7.899414 | 80 | 25 | 37.79688 | 390.4375 | 3.899902 | 1.699951 | 2.299805 | 133 | 7.459961 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
1,952 | 71.82495 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 44 | 52,016 | 39,866.4688 | null | 24.5 | white | 25.796875 | 40 | 0.467957 | 0.348999 | 26 | 1 | 0 | no | null | null | dnr after sadm | 1 | 77 | 11.699219 | 70 | 32 | 39.39844 | 119 | 2.399902 | 0.299988 | 1.799805 | 138 | 7.30957 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
1,953 | 61.19098 | 1 | male | 0 | 15 | 402 | COPD | COPD/CHF/Cirrhosis | 6 | 12 | under $11k | 0 | 27,367 | 12,431.9375 | null | 21 | white | 16.097656 | 22 | 0.910889 | 0.850952 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 15 | 100 | 16 | 80 | 25 | 36.09375 | 273.3125 | 4 | 0.799927 | 1.399902 | 136 | 7.429688 | null | null | null | null | null | no(M2 and SIP pres) | 3.993164 |
1,954 | 89.04297 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 0 | 58,008 | 38,696.375 | null | 36 | hispanic | 25.199219 | 50 | 0.5979 | 0.48999 | 14 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 6 | 59 | 12.5 | 120 | 33 | 38.59375 | 168 | null | 0.399963 | 1 | 146 | 7.389648 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
1,955 | 58.50198 | 0 | male | 0 | 12 | 1,735 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 18,372 | 13,234.2969 | null | 22.5 | white | 19.398438 | 30 | 0.806885 | 0.688965 | 1 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 12 | 77 | 3.199707 | 70 | 20 | 39.59375 | 242.84375 | 2.799805 | 4.299805 | 0.599976 | 136 | 7.509766 | null | null | null | null | null | no(M2 and SIP pres) | 2.262207 |
1,956 | 81.02698 | 0 | female | 0 | 10 | 1,733 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | >$50k | 0 | 11,976 | 8,376.7734 | null | 10.5 | white | 19.5 | 46 | 0.783936 | 0.654907 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 10 | 53 | 5.699219 | 80 | 20 | 36.09375 | 266.625 | null | null | 0.899902 | 141 | 7.479492 | null | null | null | 1 | 3 | no(M2 and SIP pres) | 3 |
1,957 | 76.10699 | 0 | female | 0 | 14 | 1,733 | COPD | COPD/CHF/Cirrhosis | 2 | null | $25-$50k | 0 | 27,917 | 21,123.0625 | null | 32.333313 | white | 17.199219 | 23 | 0.843994 | 0.743896 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 14 | 107 | 13.699219 | 78 | 8 | 37.69531 | 237.5 | 3.199707 | 0.299988 | 1.599854 | 138 | 7.339844 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,958 | 71.91498 | 1 | female | 0 | 17 | 78 | COPD | COPD/CHF/Cirrhosis | 2 | 18 | $11-$25k | 0 | 21,983 | 14,240.3828 | null | 13 | white | 16.296875 | 36 | 0.80188 | 0.679932 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 17 | 103 | 1.799805 | 80 | 25 | 36.09375 | 252.375 | null | null | 1.099854 | 142 | 7.479492 | null | null | null | 1 | 1 | adl>=4 (>=5 if sur) | 1 |
1,959 | 75.41394 | 1 | male | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 45,105 | 22,974.0938 | null | 34.5 | white | 22.097656 | 29 | 0.610962 | 0.504883 | 12 | 0 | 0 | metastatic | 0.5 | 0.4 | dnr after sadm | 7 | 63 | 15 | 112 | 22 | 38.79688 | 185 | null | null | 1.299805 | 141 | 7.389648 | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
1,960 | 90.08398 | 1 | female | 0 | 15 | 323 | COPD | COPD/CHF/Cirrhosis | 0 | 12 | null | 0 | 18,263 | 11,832.4766 | null | 11.333328 | white | 21 | 25 | 0.687988 | 0.520996 | 1 | 0 | 0 | no | 0.6 | 0.15 | no dnr | 15 | 97 | 3.799805 | 70 | 20 | 37 | 162.84375 | null | null | 1.599854 | 150 | 7.379883 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
1,961 | 78.96796 | 0 | female | 0 | 13 | 1,732 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 0 | $11-$25k | 0 | 16,741 | 12,578.8281 | null | 16 | white | 25.097656 | 44 | 0.735962 | 0.653931 | 1 | 1 | 0 | no | 0.9 | 0.75 | no dnr | 13 | 58 | 7.699219 | 65 | 24 | 35.59375 | 136.71875 | null | 0.699951 | 1.399902 | 133 | 7.519531 | null | null | null | 5 | 7 | no(M2 and SIP pres) | 7 |
1,962 | 69.66199 | 1 | female | 0 | 22 | 43 | Lung Cancer | Cancer | 2 | null | null | 0 | 41,995 | 27,412.6562 | null | 8.666664 | white | 18.5 | 37 | 0.665894 | 0.36499 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 22 | 117 | 9.298828 | 80 | 25 | 36.5 | 340 | 3.199707 | 0.399963 | 1.099854 | 136 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 3.062988 |
1,963 | 47.866 | 0 | male | 0 | 8 | 1,731 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | >$50k | 0 | 9,214 | 5,951.7148 | null | 11 | white | 12.798828 | 19 | 0.944946 | 0.905884 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 8 | 70 | 5.099609 | 80 | 16 | 36.69531 | null | 4 | 0.899902 | 1.599854 | 144 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,964 | 70.20099 | 0 | male | 0 | 7 | 1,729 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $25-$50k | 0 | 9,812 | 4,801.6211 | null | 19 | white | 21.898438 | 28 | 0.81897 | 0.757935 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 7 | 77 | 19.097656 | 68 | 30 | 38.89844 | 159.15625 | null | null | 1.299805 | 136 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,965 | 64.30396 | 0 | male | 0 | 16 | 1,728 | Coma | Coma | 1 | 16 | >$50k | 41 | 15,716 | 12,380.3438 | null | 10 | white | 17.296875 | 31 | 0.613892 | 0.549927 | 1 | 0 | 0 | yes | 0.8 | 0.9 | no dnr | 16 | 77 | 8.898438 | 62 | 28 | 37.79688 | 352 | 4.199219 | 1.5 | 1.299805 | 134 | 7.539062 | null | null | null | null | null | null | 2.257813 |
1,966 | 78.95099 | 0 | female | 0 | 13 | 1,728 | COPD | COPD/CHF/Cirrhosis | 1 | null | under $11k | 0 | 19,168 | 14,840.7812 | null | 19.5 | black | 22.898438 | 36 | 0.741943 | 0.593994 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 13 | 117 | 7.449219 | 150 | 26 | 36.09375 | 448 | null | null | 1.099854 | 134 | 7.399414 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,967 | 62.56 | 0 | male | 0 | 32 | 1,728 | Coma | Coma | 1 | 18 | >$50k | 44 | 44,236 | 25,587.5156 | null | 22.25 | black | 30.398438 | 47 | 0.302979 | 0.231995 | 2 | 0 | 0 | no | 0.7 | 0.6 | dnr after sadm | 7 | 135 | 14.5 | 140 | 28 | 38.29688 | 126.51562 | 3.299805 | null | 1.799805 | 146 | 7.459961 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,968 | 73.25397 | 0 | male | 0 | 16 | 1,727 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 54,799 | 29,236.5469 | null | 30.666656 | white | 29.796875 | 38 | 0.647949 | 0.547974 | 2 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 16 | 49 | 12.599609 | 76 | 24 | 38.39844 | 123.32812 | null | null | 1.299805 | 132 | 7.489258 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,969 | 71.32898 | 1 | female | 1 | 15 | 15 | Coma | Coma | 3 | null | null | 94 | 75,051 | 64,077.8125 | null | 34.333313 | white | 20.597656 | 46 | 0.165985 | 0.110992 | 13 | 1 | 0 | no | 0.75 | 0.25 | dnr after sadm | 14 | 67 | 16.597656 | 110 | 32 | 38.79688 | 346 | 2.399902 | null | 1 | 148 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 2.871582 |
1,970 | 55.431 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 19,018 | 6,998.5195 | null | 26 | white | 33.5 | 42 | 0.613892 | 0.508911 | 1 | 0 | 0 | yes | 0.8 | 0.8 | dnr after sadm | 6 | 130 | 1.399902 | 140 | 12 | 38.29688 | 121.42188 | 2.599609 | 1.5 | 0.699951 | 140 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 2.742188 |
1,971 | 47.26898 | 0 | male | 0 | 3 | 1,723 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 4,884 | 2,802.9844 | null | 20 | white | 19.898438 | 29 | 0.852905 | 0.757935 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 80 | 12.298828 | 80 | 30 | 36.69531 | 456 | 2.799805 | 2.599609 | 0.699951 | 134 | 7.349609 | null | null | null | 1 | null | null | 1.1669 |
1,972 | 64.77795 | 1 | male | 0 | 19 | 129 | Lung Cancer | Cancer | 1 | 10 | null | 0 | 25,747 | 15,204.4766 | null | 15 | white | 37.296875 | 29 | 0.166992 | 0.011999 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 3 | 81 | 14.599609 | 110 | 32 | 34.79688 | 267.3125 | 2.599609 | 0.699951 | 0.599976 | 135 | 7.439453 | null | null | null | 7 | 5 | adl>=4 (>=5 if sur) | 5 |
1,973 | 75.72894 | 1 | male | 1 | 34 | 34 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 44 | 168,004 | 99,285.125 | null | 28.75 | white | 24.597656 | 47 | 0.464966 | 0.345947 | 55 | 0 | 0 | no | 0.5 | 0.1 | no dnr | 34 | 70 | 6.5 | 80 | 38 | 36.59375 | 157 | 2.399902 | null | 1.699951 | 150 | 7.359375 | null | null | null | null | null | <2 mo. follow-up | 2.651367 |
1,974 | 83.61896 | 1 | male | 0 | 19 | 51 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | under $11k | 0 | 23,847 | 18,103.2031 | null | 10.666664 | white | 21 | 38 | 0.769897 | 0.695923 | 2 | 0 | 0 | no | 0.8 | 0.7 | dnr after sadm | 9 | 65 | 10.199219 | 65 | 26 | 35.79688 | 240 | 3 | 0.599976 | 1.699951 | 138 | 7.5 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
1,975 | 83.59796 | 1 | male | 1 | 6 | 6 | Coma | Coma | 2 | null | null | 55 | 8,071 | 5,081.8008 | null | 17 | white | 17.296875 | 20 | 0.44397 | 0.369995 | 1 | 0 | 0 | no | 0.01 | 0.000001 | dnr before sadm | -1 | 93 | 12.398438 | 100 | 20 | 38.29688 | 488.3125 | 3.699707 | 0.599976 | 1.5 | 144 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 2.57959 |
1,976 | 82.46399 | 1 | female | 0 | 8 | 51 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | null | 9 | 7,544 | 5,190.9688 | null | 6 | white | 22.699219 | 34 | 0.67395 | 0.501953 | 1 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 4 | 73 | 6.799805 | 70 | 20 | 35.59375 | 508 | 3.199707 | 0.599976 | 2.399902 | 141 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 3.986816 |
1,977 | 73.62097 | 1 | male | 0 | 5 | 80 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 5,234 | 3,463.6504 | null | 10 | white | 33.695313 | 26 | 0.422974 | 0.118988 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 5 | 40 | 12.798828 | 80 | 20 | 38.79688 | null | 2.899902 | 1.199951 | 1 | 137 | null | null | null | null | 0 | 5 | null | 5 |
1,978 | 47.35098 | 1 | female | 0 | 6 | 374 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $25-$50k | 0 | 7,408 | 3,852.2246 | null | 34 | white | 26.398438 | 37 | 0.843994 | 0.743896 | 1 | 1 | 0 | no | 0.95 | 0.8 | no dnr | 6 | 68 | 12.199219 | 78 | 28 | 36.29688 | 187.75 | null | null | 3.5 | 136 | 7.40918 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
1,979 | 79.06598 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 9 | 46,932 | 35,811.0312 | null | 45 | white | 34.59375 | 54 | 0.262939 | 0.156982 | 16 | 0 | 0 | yes | 0.05 | 0.000125 | dnr before sadm | 0 | 63 | 17 | 100 | 7 | 35.59375 | 266.625 | 3.599609 | 2.899902 | 2.599609 | 127 | 7.269531 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
1,980 | 77.21594 | 1 | male | 0 | 27 | 913 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | >$50k | 0 | 46,000 | 23,963.8438 | null | 21.5 | white | 29.898438 | 35 | 0.605957 | 0.5 | 3 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 1 | 44 | 9.398438 | 107 | 8 | 36.19531 | 214 | null | null | 1.199951 | 136 | 7.339844 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,981 | 46.06198 | 0 | male | 0 | 8 | 1,719 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 19 | >$50k | 0 | 10,061 | 5,333.6562 | null | 13 | white | 19.398438 | 27 | 0.862915 | 0.772949 | 1 | 0 | 0 | no | 0.5 | 0.6 | no dnr | 8 | 69 | 5.299805 | 112 | 22 | 37.89844 | null | 3.899902 | 3.099609 | 0.799927 | 140 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,982 | 75.92297 | 0 | female | 0 | 7 | 1,718 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 8,348 | 5,407.6719 | null | 11 | white | 14.898438 | 32 | 0.869995 | 0.783936 | 1 | 0 | 0 | no | 0.95 | 0.85 | no dnr | 7 | 77 | 8 | 80 | 25 | 36.69531 | 271.375 | null | null | 1 | 139 | 7.379883 | null | null | null | 6 | 2 | no(M2 and SIP pres) | 2 |
1,983 | 77.93298 | 0 | male | 0 | 13 | 1,717 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | null | 0 | 18,693 | 9,089.9141 | null | 23 | null | 23.296875 | 46 | 0.771973 | 0.697998 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 13 | 57 | 9.5 | 69 | 20 | 36.79688 | 206.09375 | 2.299805 | 0.699951 | 5.399414 | 138 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,984 | 81.07898 | 1 | female | 0 | 31 | 42 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 55,945 | 26,017.2031 | null | 28.5 | white | 26.5 | 46 | 0.649902 | 0.471985 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 31 | 53 | 12.398438 | 64 | 42 | 36.89844 | 150 | 3.699707 | 0.799927 | 1.099854 | 145 | 7.30957 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
1,985 | 28.25699 | 0 | female | 0 | 7 | 1,714 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 22,529 | 11,484.4844 | null | 22 | white | 22.296875 | 24 | 0.891968 | 0.852905 | 6 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 7 | 138 | 12.798828 | 102 | 28 | 38.19531 | 166.65625 | 3 | 1.299805 | 0.899902 | 138 | 7.479492 | null | null | null | 1 | null | null | 1.1669 |
1,986 | 77.30597 | 1 | male | 0 | 10 | 1,037 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 11,137 | 8,727.0391 | null | 12 | white | 25.5 | 33 | 0.735962 | 0.652954 | 1 | 0 | 1 | no | 0.9 | 0.75 | no dnr | 10 | 100 | 5 | 59 | 22 | 35.59375 | null | 3 | 0.399963 | 2.599609 | 142 | null | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
1,987 | 83.51294 | 1 | male | 0 | 5 | 69 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 4,691 | 3,171.3438 | null | 7 | white | 19.398438 | 37 | 0.807983 | 0.689941 | 1 | 1 | 1 | no | 0.8 | 0.7 | dnr after sadm | 3 | 93 | 8.298828 | 70 | 25 | 36.09375 | 396 | 3.699707 | 0.899902 | 2.099609 | 142 | 7.299805 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
1,988 | 68.24097 | 1 | female | 0 | 6 | 64 | CHF | COPD/CHF/Cirrhosis | 3 | 15 | under $11k | 0 | 5,608 | 3,866.9336 | null | 14 | white | 16.5 | 35 | 0.886963 | 0.810913 | 1 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 6 | 73 | 3.799805 | 60 | 20 | 37.19531 | 347.5625 | null | 2.399902 | 1.199951 | 136 | 7.489258 | null | null | null | 2 | 3 | null | 3 |
1,989 | 78.245 | 1 | female | 1 | 42 | 42 | COPD | COPD/CHF/Cirrhosis | 3 | null | under $11k | 0 | 69,147 | 33,901.3438 | null | 22.75 | white | 25.597656 | 28 | 0.695923 | 0.530884 | 1 | 0 | 0 | no | 0.95 | 0.75 | dnr after sadm | 17 | 53 | 17.296875 | 107 | 8 | 35.59375 | 320 | null | 0.5 | 1.099854 | 143 | 7.369141 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
1,990 | 60.77197 | 1 | male | 0 | 7 | 248 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | null | 0 | 8,159 | 4,635.6094 | null | 12 | white | 11.5 | 25 | 0.928955 | 0.878906 | 2 | 1 | 0 | no | 0.75 | 0.7 | no dnr | 7 | 111 | 7.199219 | 64 | 20 | 36.39844 | 336.625 | 4.599609 | 1.099854 | 1.799805 | 141 | 7.549805 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,991 | 67.96997 | 1 | male | 0 | 11 | 1,134 | MOSF w/Malig | ARF/MOSF | 2 | null | under $11k | 0 | 27,302 | 15,819 | null | 16.5 | black | 22.699219 | 34 | 0.608887 | 0.50293 | 4 | 1 | 0 | metastatic | 0.8 | 0.7 | no dnr | 11 | 145 | 17.398438 | 70 | 24 | 38.19531 | 193.875 | 2.899902 | null | 5.5 | 138 | 7.40918 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
1,992 | 75.38098 | 0 | male | 0 | 17 | 1,708 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | >$50k | 0 | 25,486 | 14,188.5703 | null | 15.333328 | white | 16.699219 | 21 | 0.85498 | 0.804932 | 2 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 17 | 115 | 6.5 | 59 | 24 | 37.89844 | 486 | 2.5 | 0.5 | 1.699951 | 141 | 7.509766 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
1,993 | 61.56299 | 0 | male | 0 | 4 | 1,708 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 9 | 7,588 | 3,814.6152 | null | 4 | white | 14.199219 | 16 | 0.901978 | 0.866943 | 1 | 1 | 0 | no | 1 | 1 | no dnr | 4 | 103 | 7.799805 | 70 | 20 | 36.09375 | 447.5625 | 3.099609 | 0.699951 | 1.099854 | 140 | 7.579102 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,994 | 69.23199 | 0 | female | 0 | 32 | 1,707 | Colon Cancer | Cancer | 2 | 12 | null | 0 | 37,893 | 26,417.5156 | null | 14 | black | 19 | 35 | 0.779907 | 0.539917 | 1 | 1 | 0 | metastatic | 0.75 | 0.5 | dnr after sadm | 9 | 100 | 0.799927 | 80 | 15 | 37.79688 | null | 2.699707 | 1.899902 | 0.699951 | 140 | null | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
1,995 | 89.32794 | 1 | male | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 86,069 | 34,868 | null | 50 | null | 37.796875 | 61 | 0.348999 | 0.231995 | 1 | 0 | 0 | no | 0.3 | 0.28 | dnr after sadm | 16 | 53 | 4.099609 | 230 | 12 | 39.69531 | 142 | 2.099609 | 5.399414 | 1 | 146 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 3.07959 |
1,996 | 84.35297 | 0 | male | 0 | 16 | 1,705 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 19,014 | 11,332.1406 | null | 9.666664 | white | 19.699219 | 24 | 0.802979 | 0.737915 | 1 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 16 | 65 | 14.398438 | 68 | 26 | 38.09375 | 385.125 | 3 | 0.599976 | 0.5 | 133 | 7.439453 | null | null | null | null | null | null | 3.170898 |
1,997 | 73.63397 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 10 | $11-$25k | 9 | 21,516 | 13,772.5234 | null | 5.5 | white | 18.097656 | 31 | 0.74292 | 0.661987 | 9 | 1 | 0 | yes | 0.5 | 0.1 | no dnr | 11 | 120 | 17.5 | 90 | 35 | 37.69531 | null | 3.199707 | null | 1.099854 | 145 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,998 | 87.41699 | 0 | female | 0 | 19 | 1,703 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | under $11k | 0 | 25,572 | 13,947.4531 | null | 12.333328 | white | 24.097656 | 38 | 0.581909 | 0.472961 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | dnr after sadm | 1 | 70 | 13.398438 | 59 | 28 | 36.09375 | 404 | 2.399902 | 0.799927 | 1.5 | 130 | 7.459961 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
1,999 | 75.34296 | 0 | female | 0 | 89 | 1,701 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 9 | 81,770 | 57,706.5312 | null | 8.75 | white | 21 | 27 | 0.772949 | 0.638916 | 1 | 0 | 0 | no | 0.8 | 0.5 | dnr after sadm | 16 | 58 | 5.5 | 98 | 24 | 36.69531 | 196.40625 | 3.899902 | 0.799927 | 0.599976 | 130 | 7.389648 | null | null | null | null | null | null | 3.299805 |
2,000 | 78.53497 | 1 | female | 0 | 10 | 14 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | null | 41 | 10,645 | 7,270.207 | null | 11 | white | 19.296875 | 15 | 0.672974 | 0.500977 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr before sadm | -1 | 77 | 10 | 70 | 20 | 36.59375 | 195 | null | null | 0.5 | 137 | 7.179688 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.